Page last updated: 2024-10-17

hydrogen sulfide and Cardiovascular Diseases

hydrogen sulfide has been researched along with Cardiovascular Diseases in 72 studies

Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains unclear."9.12Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? ( Deharo, P; Fromonot, J; Guieu, R; Marlinge, M; Mottola, G; Paganelli, F; Ruf, J, 2021)
"Hydrogen sulfide (H2 S) has traditionally been viewed as a highly toxic gas; however, recent studies have implicated H2 S as a third member of the gasotransmitter family, exhibiting properties similar to NO and carbon monoxide."6.52Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. ( Ferro, A; Ji, Y; Ma, Y; Meng, G; Xie, L, 2015)
" H2S therapy can also restore eNOS function and NO bioavailability and attenuate the pathological changes in the liver in L-NAME-induced hypertensive rats."5.40Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. ( Dai, J; Duan, X; Ji, W; Jiang, X; Liu, S; Wu, Y; Yang, T, 2014)
"The influence of hyperhomocysteinemia (HHCy) on cardiovascular disease (CVD) remains unclear."5.12Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link? ( Deharo, P; Fromonot, J; Guieu, R; Marlinge, M; Mottola, G; Paganelli, F; Ruf, J, 2021)
"DNA-based sensors can detect disease biomarkers, including acetone and ethanol for diabetes and H2S for cardiovascular diseases."3.83Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics. ( Cranford, SW; Wang, ML; Zhang, W, 2016)
"Hydrogen sulfide plays a significant part in anti-oxidative stress, which may participate in the general mechanism of ferroptosis and regulate it by some signaling molecules."3.01Ferroptosis and Hydrogen Sulfide in Cardiovascular Disease. ( Gui, DD; Jiang, ZS; Luo, W; Ma, Y; Ren, Z; Wu, ZF; Yan, BJ, 2023)
"Cardiovascular diseases are recognized to be a major cause of people morbidity and mortality."2.66Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology. ( Bian, JS; Cao, L; Huang, DJ; Nie, XW; Sun, HJ; Sun, MT; Wu, ZY; Zhu, MY, 2020)
"Hydrogen sulfide (H2S) is a signaling gasotransmitter, involved in different physiological and pathological processes."2.53Biochemistry and therapeutic potential of hydrogen sulfide - reality or fantasy? ( Brodek, P; Olas, B, 2016)
"Hydrogen sulfide (H2 S) has traditionally been viewed as a highly toxic gas; however, recent studies have implicated H2 S as a third member of the gasotransmitter family, exhibiting properties similar to NO and carbon monoxide."2.52Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. ( Ferro, A; Ji, Y; Ma, Y; Meng, G; Xie, L, 2015)
"Hydrogen sulfide (H2S) is a well-known toxic gas with the characteristic smell of rotten eggs."2.50Hydrogen sulfide as a potent cardiovascular protective agent. ( Cayabyab, FS; Chen, ZW; Cui, LB; Tang, CK; Wu, K; Yu, XH; Zheng, XL, 2014)
"Hydrogen sulfide (H(2)S) has traditionally been considered a toxic environmental pollutant."2.48Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? ( Gong, QH; Liu, XH; Pan, LL; Yang, HB; Zhu, YZ, 2012)
"Hydrogen sulfide (H(2)S) has been found to play an important role as a signal molecule in regulating cell survival."2.47Hydrogen sulfide in cell survival: a double-edged sword. ( Yang, G, 2011)
" Nitrates that have been used for over a century and nebivolol, a third-generation b-blocker with vasodilating properties by increasing bioavailability of NO, provide convincing arguments that the compounds acting via NO pathway will remain an important class of cardiovascular drugs."2.46[The role of nitric oxide, hydrogen sulfide and carbon monoxide in the regulation of the circulatory system and their pharmacotherapeutic potential]. ( Ufnal, M; Żera, T, 2010)
"Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases."2.43[A new strategy to treat hyperhomocysteinemia]. ( Chang, L; Du, JB; Geng, B; Tang, CS, 2005)
"Hydrogen Sulfide has been found to be produced endogenously in amounts that cause vasodilatation."2.43Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about? ( Pearson, RJ; Wang, R; Wilson, T, 2006)
"Hydrogen sulfide has emerged as an important gaseous signaling molecule and a regulator of critical biological processes."1.56Reactive Sulfur Species: A New Redox Player in Cardiovascular Pathophysiology. ( Kevil, CG; Kolluru, GK; Shen, X, 2020)
"Hydrogen sulfide also plays an important role in promoting resolution of inflammation, and restoration of normal tissue function."1.42Anti-inflammatory and cytoprotective properties of hydrogen sulfide. ( Gemici, B; Wallace, JL, 2015)
" H2S therapy can also restore eNOS function and NO bioavailability and attenuate the pathological changes in the liver in L-NAME-induced hypertensive rats."1.40Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. ( Dai, J; Duan, X; Ji, W; Jiang, X; Liu, S; Wu, Y; Yang, T, 2014)
"Hydrogen sulfide (H2S) has been implicated in regulating cardiovascular pathophysiology in experimental models."1.39Plasma free H2S levels are elevated in patients with cardiovascular disease. ( Akkus, NI; Glawe, JD; Kevil, CG; Pardue, S; Peter, EA; Reddy, P; Shah, SH; Shen, X; Varma, J; Zhang, WW, 2013)
" Endogenous H2S bioavailability is regulated by several enzymes involved in the biosynthesis of cysteine."1.35Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes. ( Lefer, DJ, 2008)
"Hydrogen sulfide has recently been considered to have an important role as a gasotransmitter in the cardiovascular system as well as in the central nervous system, but its action seems directly related to the presence of nitric oxide/nitric oxide-derivatives."1.35Hydrogen sulfide induces nitric oxide release from nitrite. ( Grossi, L, 2009)

Research

Studies (72)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.39)18.7374
1990's1 (1.39)18.2507
2000's10 (13.89)29.6817
2010's42 (58.33)24.3611
2020's18 (25.00)2.80

Authors

AuthorsStudies
Peng, W1
Guo, W1
Zheng, Y2
Leitão, R1
de Oliveira, GV1
Rezende, C1
Volino-Souza, M1
Mesquita, J1
de Carvalho, LL1
Alvares, TS1
Zhang, H1
Du, J2
Huang, Y1
Tang, C2
Jin, H2
Wu, ZF1
Yan, BJ2
Luo, W2
Gui, DD2
Ren, Z2
Ma, Y2
Jiang, ZS2
Huerta de la Cruz, S1
Santiago-Castañeda, CL1
Rodríguez-Palma, EJ1
Medina-Terol, GJ1
López-Preza, FI1
Rocha, L1
Sánchez-López, A1
Freeman, K1
Centurión, D1
Ma, JS1
Chen, J1
Huang, H1
Islam, MZ1
Shackelford, RE1
Nuvolone, D1
Petri, D1
Biggeri, A1
Barbone, F1
Voller, F1
Peng, LJ1
Wei, DH1
Liu, LS1
Zhang, DW1
Di Giovanni, E1
Buonvino, S1
Amelio, I1
Melino, S1
Kolluru, GK3
Shen, X4
Kevil, CG5
Sun, HJ1
Wu, ZY1
Cao, L2
Zhu, MY1
Nie, XW1
Huang, DJ1
Sun, MT1
Bian, JS2
Chen, Y1
Zhang, F1
Yin, J2
Wu, S1
Zhou, X1
Teoh, JP1
Li, X2
Simoncini, T1
Zhu, D1
Fu, X1
Paganelli, F1
Mottola, G1
Fromonot, J1
Marlinge, M1
Deharo, P1
Guieu, R1
Ruf, J1
Wang, YZ1
Ngowi, EE1
Wang, D2
Qi, HW1
Jing, MR1
Zhang, YX1
Cai, CB1
He, QL1
Khattak, S1
Khan, NH1
Jiang, QY1
Ji, XY1
Wu, DD1
Ding, Q1
Zhu, YZ5
Zhu, J1
Yang, G2
Wallace, JL2
Vaughan, D1
Dicay, M1
MacNaughton, WK1
de Nucci, G1
Yu, W1
Zhang, Z1
Mistry, RK1
Brewer, AC1
Kenessary, D1
Kenessary, A1
Kenessariyev, UI1
Juszkiewicz, K1
Amrin, MK1
Erzhanova, AE1
Kanagy, NL1
Cao, X1
Wu, Z1
Xiong, S1
Sethi, G1
Rajpal, S1
Katikaneni, P1
Deshotels, M1
Pardue, S2
Glawe, J2
Akkus, N1
Modi, K1
Bhandari, R1
Dominic, P1
Reddy, P2
Lin, Z1
Altaf, N1
Li, C1
Chen, M1
Pan, L1
Xie, L2
Fu, H1
Han, Y1
Ji, Y2
Wang, XL1
Wang, ZY1
Guo, XQ1
Zhang, YH1
Pan, LL2
Liu, XH2
Wen, YD1
Wang, H1
Dyson, RM1
Palliser, HK1
Wilding, N1
Kelly, MA1
Chwatko, G1
Glowacki, R1
Berry, MJ1
Ni, X1
Wright, IMR1
Li, Z1
Polhemus, DJ2
Lefer, DJ5
Jin, L1
Yu, Y1
Esse, R1
Barroso, M1
Tavares de Almeida, I1
Castro, R1
Rajendran, S1
Peter, EA1
Shah, SH1
Glawe, JD1
Zhang, WW1
Akkus, NI1
Varma, J1
Song, P1
Zou, MH1
Yu, XH1
Cui, LB1
Wu, K1
Zheng, XL1
Cayabyab, FS1
Chen, ZW1
Tang, CK1
Meng, G1
Ferro, A1
Ji, W1
Liu, S1
Dai, J1
Yang, T1
Jiang, X1
Duan, X1
Wu, Y1
Tian, H1
Lewis, RJ1
Copley, GB1
Gemici, B1
Wu, D1
Hu, Q1
Ma, F1
Zhang, W1
Wang, ML1
Cranford, SW1
Hackfort, BT1
Mishra, PK1
Brodek, P1
Olas, B1
Tomasova, L1
Konopelski, P1
Ufnal, M2
Bazer, FW1
Gao, H1
Jobgen, W1
Johnson, GA1
Li, P1
McKnight, JR1
Satterfield, MC1
Spencer, TE1
Wu, G1
Wang, XB2
Jin, HF5
Tang, CS6
Du, JB7
Grossi, L1
Predmore, BL1
Perna, AF1
Luciano, MG1
Ingrosso, D1
Raiola, I1
Pulzella, P1
Sepe, I1
Lanza, D1
Violetti, E1
Capasso, R1
Lombardi, C1
De Santo, NG1
Lavu, M1
Bhushan, S1
Hart, JL1
Gong, QH1
Yang, HB1
Żera, T1
Skovgaard, N1
Gouliaev, A1
Aalling, M1
Simonsen, U1
Chen, S1
Epelman, S1
Tang, WH1
KAIPAINEN, WJ1
Moore, PK1
Bhatia, M1
Moochhala, S1
Geng, B2
Yan, H1
Zhong, GZ1
Zhang, CY1
Chen, XB1
Jiang, HF1
Chang, L1
Pearson, RJ1
Wilson, T1
Wang, R1
Szabó, C1
Jäppinen, P1
Tola, S1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Aged Garlic on Vascular Function and Muscle Oxygenation Responses in the Elderly[NCT04008693]28 participants (Actual)Interventional2019-08-26Completed
Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Twin Cities of Pakistan[NCT05011032]0 participants (Actual)Interventional2021-08-12Withdrawn (stopped due to Ethical approval was not done. Hence the funding was withhold.)
Plasma Measurement of Hydrogen Sulfide, Nitric Oxide and Stress Hyperglycemia in Acute Myocardial Infarction[NCT03829605]50 participants (Anticipated)Observational2019-02-15Not yet recruiting
Hydrogen Sulfide and Peripheral Arterial Disease[NCT01407172]252 participants (Actual)Observational2011-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

43 reviews available for hydrogen sulfide and Cardiovascular Diseases

ArticleYear
Recent Development of Hydrogen Sulfide Therapeutics in the Treatment of Cardiovascular Diseases.
    Current topics in medicinal chemistry, 2021, Volume: 21, Issue:24

    Topics: Animals; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Prodrugs

2021
Hydrogen Sulfide Regulates Macrophage Function in Cardiovascular Diseases.
    Antioxidants & redox signaling, 2023, Volume: 38, Issue:1-3

    Topics: Cardiovascular Diseases; Cystathionine gamma-Lyase; Gasotransmitters; Humans; Hydrogen Sulfide; Macr

2023
Ferroptosis and Hydrogen Sulfide in Cardiovascular Disease.
    Current medicinal chemistry, 2023, Volume: 30, Issue:16

    Topics: Cardiovascular Diseases; Cell Death; Ferroptosis; Heart; Humans; Hydrogen Sulfide; Lipid Peroxidatio

2023
Targeting hydrogen sulfide and nitric oxide to repair cardiovascular injury after trauma.
    Nitric oxide : biology and chemistry, 2022, Dec-01, Volume: 129

    Topics: Cardiovascular Diseases; Cardiovascular System; Gasotransmitters; Humans; Hydrogen Sulfide; Nitric O

2022
[Role and mechanism of hydrogen sulfide in vascular calcification].
    Sheng li xue bao : [Acta physiologica Sinica], 2022, Dec-25, Volume: 74, Issue:6

    Topics: Animals; Antioxidants; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Mammals;

2022
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:1

    Topics: Animals; Apoptosis; Autophagy; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System

2020
Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.
    Pharmacological research, 2020, Volume: 159

    Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sul

2020
Protective mechanisms of hydrogen sulfide in myocardial ischemia.
    Journal of cellular physiology, 2020, Volume: 235, Issue:12

    Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Mitochondria;

2020
Estrogen-Mediated Gaseous Signaling Molecules in Cardiovascular Disease.
    Trends in endocrinology and metabolism: TEM, 2020, Volume: 31, Issue:10

    Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Estrogens; Female; Gasotransmitters; Humans; Hydr

2020
Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
    International journal of molecular sciences, 2021, Feb-08, Volume: 22, Issue:4

    Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Rece

2021
The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases.
    International journal of molecular sciences, 2021, Feb-23, Volume: 22, Issue:4

    Topics: Administration, Inhalation; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cell Movement;

2021
H
    Nitric oxide : biology and chemistry, 2021, 11-01, Volume: 116

    Topics: Animals; Cardiovascular Diseases; Extracellular Matrix; Gasotransmitters; Humans; Hydrogen Sulfide

2021
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
    Antioxidants & redox signaling, 2018, 06-01, Volume: 28, Issue:16

    Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relatio

2018
Sulfur-containing gaseous signal molecules, ion channels and cardiovascular diseases.
    British journal of pharmacology, 2018, Volume: 175, Issue:8

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Ion Channels; Sulfur Dioxide

2018
Redox-Dependent Regulation of Sulfur Metabolism in Biomolecules: Implications for Cardiovascular Health.
    Antioxidants & redox signaling, 2019, 03-01, Volume: 30, Issue:7

    Topics: Amino Acids; Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Metabolic Networks and Path

2019
The role of hydrogen sulfide in cyclic nucleotide signaling.
    Biochemical pharmacology, 2018, Volume: 149

    Topics: Animals; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Hypertension; Nucleoti

2018
[Advances in hydrogen sulfide and hydrogen sulfide-releasing drugs].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2016, Volume: 51, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Central Nervous System Ag

2016
[Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
    Sheng li ke xue jin zhan [Progress in physiology], 2017, Volume: 48, Issue:1

    Topics: Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Immune System Diseases; Inflamma

2017
The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Cardiovascular Diseases; Drug Development; Humans; Hydrogen Sulfide

2018
Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease.
    Circulation research, 2018, 08-17, Volume: 123, Issue:5

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Protein Processing, Post-Translational;

2018
The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
    International journal of molecular sciences, 2019, Feb-17, Volume: 20, Issue:4

    Topics: Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Homocysteine; Humans; Hydrogen Sulfide;

2019
Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.
    Comprehensive Physiology, 2019, 06-12, Volume: 9, Issue:3

    Topics: Cardiovascular Diseases; Humans; Hydrogen Sulfide; Intercellular Signaling Peptides and Proteins; Is

2019
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
    Circulation research, 2014, Feb-14, Volume: 114, Issue:4

    Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Nitri

2014
Hydrogen sulfide as a potent cardiovascular protective agent.
    Clinica chimica acta; international journal of clinical chemistry, 2014, Nov-01, Volume: 437

    Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Humans; Hydrogen Sulfide

2014
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.
    British journal of pharmacology, 2015, Volume: 172, Issue:23

    Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; China; Humans; Hydrogen Sulfide; Hyperten

2015
Advances in the study on endogenous sulfur dioxide in the cardiovascular system.
    Chinese medical journal, 2014, Volume: 127, Issue:21

    Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sulfide; Nitric Oxide; Sul

2014
Chronic low-level hydrogen sulfide exposure and potential effects on human health: a review of the epidemiological evidence.
    Critical reviews in toxicology, 2015, Volume: 45, Issue:2

    Topics: Air Pollutants; Cardiovascular Diseases; Dose-Response Relationship, Drug; Epidemiological Monitorin

2015
Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.
    American journal of physiology. Heart and circulatory physiology, 2016, Apr-01, Volume: 310, Issue:7

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; MicroRNAs; Signal Transduction

2016
Biochemistry and therapeutic potential of hydrogen sulfide - reality or fantasy?
    Postepy higieny i medycyny doswiadczalnej (Online), 2016, Aug-11, Volume: 70, Issue:0

    Topics: Animals; Brain; Cardiovascular Diseases; Cysteine; Endothelial Cells; Humans; Hydrogen Sulfide; Mito

2016
Gut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System Homeostasis.
    Molecules (Basel, Switzerland), 2016, Nov-17, Volume: 21, Issue:11

    Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Gastrointestinal Microbiom

2016
Amino acids and gaseous signaling.
    Amino acids, 2009, Volume: 37, Issue:1

    Topics: Amino Acids; Animals; Carbon Monoxide; Cardiovascular Diseases; Energy Metabolism; Humans; Hydrogen

2009
Significance of endogenous sulphur-containing gases in the cardiovascular system.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7

    Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Male; Mice; O

2010
[Role of gas signaling molecule hydrogen sulfide in cardiovascular diseases].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2009, Volume: 11, Issue:9

    Topics: Animals; Cardiovascular Diseases; Coronary Disease; Humans; Hydrogen Sulfide; Hypertension; Hyperten

2009
Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2010, Volume: 20, Issue:5 Suppl

    Topics: Cardiovascular Diseases; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Humans; Hydrogen Su

2010
Role of sulfur-containing gaseous substances in the cardiovascular system.
    Frontiers in bioscience (Elite edition), 2011, 01-01, Volume: 3, Issue:2

    Topics: Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Endothelium; Humans; Hydrogen Sulfi

2011
Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?
    Antioxidants & redox signaling, 2012, Jul-01, Volume: 17, Issue:1

    Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Signal Transd

2012
Hydrogen sulfide in cell survival: a double-edged sword.
    Expert review of clinical pharmacology, 2011, Volume: 4, Issue:1

    Topics: Animals; Cardiovascular Diseases; Cell Proliferation; Cell Survival; Cytoprotection; Cytotoxins; Hum

2011
[The role of nitric oxide, hydrogen sulfide and carbon monoxide in the regulation of the circulatory system and their pharmacotherapeutic potential].
    Kardiologia polska, 2010, Volume: 68 Suppl 5

    Topics: Carbon Monoxide; Cardiovascular Diseases; Cardiovascular System; Coronary Circulation; Humans; Hydro

2010
The role of endogenous H2S in cardiovascular physiology.
    Current pharmaceutical biotechnology, 2011, Volume: 12, Issue:9

    Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans; Hydrogen Sulfide;

2011
[A new strategy to treat hyperhomocysteinemia].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2005, Apr-18, Volume: 37, Issue:2

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Metallothionein; T

2005
[Significance of gaseous signal molecule in the pathogenesis of cardiovascular diseases].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2005, Volume: 27, Issue:4

    Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Hypertens

2005
Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about?
    Clinical and investigative medicine. Medecine clinique et experimentale, 2006, Volume: 29, Issue:3

    Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Humans; Hydrogen Sulfide; Nitric Oxide; Pot

2006
Hydrogen sulphide and its therapeutic potential.
    Nature reviews. Drug discovery, 2007, Volume: 6, Issue:11

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Inflammation; Motor Activity; Shock, Hem

2007

Trials

1 trial available for hydrogen sulfide and Cardiovascular Diseases

ArticleYear
Improved microvascular reactivity after aged garlic extract intake is not mediated by hydrogen sulfide in older adults at risk for cardiovascular disease: a randomized clinical trial.
    European journal of nutrition, 2022, Volume: 61, Issue:7

    Topics: Aged; Cardiovascular Diseases; Garlic; Humans; Hydrogen Sulfide; Male; Microcirculation; Middle Aged

2022

Other Studies

28 other studies available for hydrogen sulfide and Cardiovascular Diseases

ArticleYear
Pioglitazone treatment increases the cellular acid-labile and protein-bound sulfane sulfur fractions.
    Biochemical and biophysical research communications, 2023, 08-30, Volume: 670

    Topics: Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Cystathionine gamma-Lyase; Glutathi

2023
Health effects associated with short-term exposure to hydrogen sulfide from geothermal power plants: a case-crossover study in the geothermal areas in Tuscany.
    International archives of occupational and environmental health, 2020, Volume: 93, Issue:6

    Topics: Aged; Air Pollutants; Cardiovascular Diseases; Emergency Service, Hospital; Environmental Exposure;

2020
Glutathione-Allylsulfur Conjugates as Mesenchymal Stem Cells Stimulating Agents for Potential Applications in Tissue Repair.
    International journal of molecular sciences, 2020, Feb-28, Volume: 21, Issue:5

    Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Cell Differentiation; Cell Hypoxia; Cell Movement

2020
Reactive Sulfur Species: A New Redox Player in Cardiovascular Pathophysiology.
    Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:4

    Topics: Biological Availability; Cardiovascular Diseases; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfid

2020
The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.
    Advances in experimental medicine and biology, 2021, Volume: 1315

    Topics: Cardiovascular Diseases; Cardiovascular System; Epigenesis, Genetic; Humans; Hydrogen Sulfide; Vasod

2021
Human health cost of hydrogen sulfide air pollution from an oil and gas Field.
    Annals of agricultural and environmental medicine : AAEM, 2017, Jun-08, Volume: 24, Issue:2

    Topics: Air Pollutants; Air Pollution; Cardiovascular Diseases; Health Care Costs; Humans; Hydrogen Sulfide;

2017
The pleiotropic effects of hydrogen sulfide.
    American journal of physiology. Heart and circulatory physiology, 2018, 01-01, Volume: 314, Issue:1

    Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Gasotransmitters; Hemodynamics; Humans; Hyd

2018
Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease.
    Redox biology, 2018, Volume: 15

    Topics: Adult; Aged; Biological Availability; Black or African American; Bridged Bicyclo Compounds; Cardiova

2018
Hydrogen sulfide attenuates oxidative stress-induced NLRP3 inflammasome activation via S-sulfhydrating c-Jun at Cys269 in macrophages.
    Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:9 Pt B

    Topics: Animals; Antioxidants; Cardiovascular Diseases; Cell Line; Cysteine; Humans; Hydrogen Peroxide; Hydr

2018
Microvascular circulatory dysregulation driven in part by cystathionine gamma-lyase: A new paradigm for cardiovascular compromise in the preterm newborn.
    Microcirculation (New York, N.Y. : 1994), 2019, Volume: 26, Issue:2

    Topics: Animals; Animals, Newborn; Blood Flow Velocity; Cardiovascular Diseases; Cystathionine gamma-Lyase;

2019
Bioactive Small Molecules in the Pathogenesis and Pharmacology of Cardiovascular Diseases: From Bench to Bedside.
    Current topics in medicinal chemistry, 2018, Volume: 18, Issue:16

    Topics: Antibodies, Monoclonal; Cardiovascular Diseases; Humans; Hydrogen Sulfide; MicroRNAs; Reactive Oxyge

2018
Plasma free H2S levels are elevated in patients with cardiovascular disease.
    Journal of the American Heart Association, 2013, Oct-23, Volume: 2, Issue:5

    Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher

2013
Plasma free H2S levels are elevated in patients with cardiovascular disease.
    Journal of the American Heart Association, 2013, Oct-23, Volume: 2, Issue:5

    Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher

2013
Plasma free H2S levels are elevated in patients with cardiovascular disease.
    Journal of the American Heart Association, 2013, Oct-23, Volume: 2, Issue:5

    Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher

2013
Plasma free H2S levels are elevated in patients with cardiovascular disease.
    Journal of the American Heart Association, 2013, Oct-23, Volume: 2, Issue:5

    Topics: Cardiovascular Diseases; Female; Humans; Hydrogen Sulfide; Male; Middle Aged; Nitric Oxide; Peripher

2013
Redox regulation of endothelial cell fate.
    Cellular and molecular life sciences : CMLS, 2014, Volume: 71, Issue:17

    Topics: Animals; Apoptosis; Cardiovascular Diseases; Cell Cycle; Cell Movement; Cell Transdifferentiation; C

2014
Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
    Chinese medical journal, 2014, Volume: 127, Issue:21

    Topics: Animals; Cardiovascular Diseases; Hydrogen Sulfide; Hypertension; Liver; Male; NG-Nitroarginine Meth

2014
Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
    Methods in enzymology, 2015, Volume: 555

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cystathionine beta-Syntha

2015
Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway.
    Oxidative medicine and cellular longevity, 2016, Volume: 2016

    Topics: Animals; Aorta; Carbazoles; Cardiovascular Diseases; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP

2016
Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics.
    Scientific reports, 2016, Jan-11, Volume: 6

    Topics: Acetone; Adenine; Biomarkers; Biosensing Techniques; Cardiovascular Diseases; Cytosine; Diabetes Mel

2016
Potential importance of alterations in hydrogen sulphide (H2S) bioavailability in diabetes.
    British journal of pharmacology, 2008, Volume: 155, Issue:5

    Topics: Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Mellitus, Type 1;

2008
Hydrogen sulfide induces nitric oxide release from nitrite.
    Bioorganic & medicinal chemistry letters, 2009, Nov-01, Volume: 19, Issue:21

    Topics: Cardiovascular Diseases; Cardiovascular System; Central Nervous System; Central Nervous System Disea

2009
Frontiers in research series: The pathophysiological significance of sulphur-containing gases. Introduction.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Mice; Oxides; Rats; Sulfur Compounds

2010
Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
    Journal of cardiovascular translational research, 2010, Volume: 3, Issue:5

    Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Drug Design; Humans; Hydrogen Sulfide; Sign

2010
Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential.
    Clinical science (London, England : 1979), 2011, Volume: 120, Issue:6

    Topics: Animals; Atherosclerosis; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Humans

2011
Adequate hydrogen sulfide, healthy circulation.
    Chinese medical journal, 2011, Volume: 124, Issue:21

    Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Signal Transduction

2011
H(2)S--the newest gaseous messenger on the block.
    Journal of cardiac failure, 2012, Volume: 18, Issue:8

    Topics: Cardiovascular Diseases; Endothelium, Vascular; Gases; Humans; Hydrogen Sulfide

2012
Hydrogen sulfide in toxication; rapidly transient changes in the electrocardiogram suggestive of myocardial infarction.
    Annales medicinae internae Fenniae, 1954, Volume: 43, Issue:2

    Topics: Cardiovascular Diseases; Electrocardiography; Humans; Hydrogen Sulfide; Myocardial Infarction; Poiso

1954
Hydrogen sulfide: from the smell of the past to the mediator of the future?
    Trends in pharmacological sciences, 2003, Volume: 24, Issue:12

    Topics: Cardiovascular Diseases; Cardiovascular System; Central Nervous System; Central Nervous System Disea

2003
[Hydrogen sulfide: a novel cardiovascular functional regulatory gas factor].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2004, Volume: 36, Issue:1

    Topics: Animals; Cardiovascular Diseases; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension, Pulmona

2004
Cardiovascular mortality among pulp mill workers.
    British journal of industrial medicine, 1990, Volume: 47, Issue:4

    Topics: Cardiovascular Diseases; Cohort Studies; Coronary Disease; Finland; Humans; Hydrogen Sulfide; Male;

1990